About
Medicines that harness IL-22 biology
Areas of Focus
Categories
Biologics & Biopharmaceutical
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
166
By Phase
PHASE2: 1PHASE1: 1
By Status
ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06611930Lead Sponsor
CK-0045 Proof-of-concept Study in Participants With Overweight / Obesity and Type 2 Diabetes
PHASE2Active, not recruiting
90 participants
Started: Sep 16, 2024 · Completed: Jan 7, 2026
NCT05712876Lead Sponsor
A Phase 1 Study to Investigate Safety, Tolerability, and Pharmacokinetics of CK-0045 in Healthy Participants and Otherwise Healthy Participants With Obesity
PHASE1Completed
76 participants
Started: Dec 26, 2022 · Completed: Jan 4, 2024
Locations (1)
Headquarters
Søborg, Denmark
Map
Loading map...